Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Understanding the host genetics of chronic hepatitis B and C.

Thursz M, Yee L, Khakoo S.

Semin Liver Dis. 2011 May;31(2):115-27. doi: 10.1055/s-0031-1276642. Epub 2011 May 2. Review.

PMID:
21538279
2.

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

Lin CL, Kao JH.

J Biomed Sci. 2008 Mar;15(2):137-45. Epub 2007 Dec 5. Review.

PMID:
18058038
3.

The clinical implications of hepatitis B virus genotype: Recent advances.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30. doi: 10.1111/j.1440-1746.2010.06541.x. Review.

PMID:
21199523
4.

Genetic susceptibility in chronic viral hepatitis.

Thursz M.

Antiviral Res. 2001 Nov;52(2):113-6. Review.

PMID:
11672820
5.
6.

The influence of the human genome on chronic viral hepatitis outcome.

de Andrade DR Jr, de Andrade DR.

Rev Inst Med Trop Sao Paulo. 2004 May-Jun;46(3):119-26. Epub 2004 Jul 20. Review.

7.

Inflammation and repair in viral hepatitis C.

Neuman MG, Sha K, Esguerra R, Zakhari S, Winkler RE, Hilzenrat N, Wyse J, Cooper CL, Seth D, Gorrell MD, Haber PS, McCaughan GW, Leo MA, Lieber CS, Voiculescu M, Buzatu E, Ionescu C, Dudas J, Saile B, Ramadori G.

Dig Dis Sci. 2008 Jun;53(6):1468-87. Review.

PMID:
17994278
8.

IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies.

Clark PJ, Thompson AJ, McHutchison JG.

Am J Gastroenterol. 2011 Jan;106(1):38-45. doi: 10.1038/ajg.2010.370. Epub 2010 Oct 5. Review.

PMID:
20924369
9.

Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.

Asselah T, Bièche I, Paradis V, Bedossa P, Vidaud M, Marcellin P.

Semin Liver Dis. 2007 Feb;27(1):13-27. Review.

PMID:
17295174
10.
11.

Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.

Wang FS, Zhang Z.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):499-512. doi: 10.1586/egh.09.50. Review.

PMID:
19817672
12.

Viral hepatitis: human genes that limit infection.

Grünhage F, Nattermann J.

Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):709-23. doi: 10.1016/j.bpg.2010.07.009. Review.

PMID:
20955972
13.

[Genetics and hepatitis C treatment: towards a personalized treatment?].

Lens García S, Coto-Llerena M, Pérez del Pulgar Gallart S, Forns Bernhardt X.

Gastroenterol Hepatol. 2011 May;34(5):352-60. doi: 10.1016/j.gastrohep.2010.12.008. Epub 2011 Mar 21. Review. Spanish.

PMID:
21420759
14.

[Viruses and primary hepatocellular carcinoma].

Jablonská M.

Cas Lek Cesk. 1997 Oct 22;136(20):619-23. Review. Czech.

PMID:
9490205
15.

Hepatitis B virus infection and liver transplantation.

Kennedy M, Alexopoulos SP.

Curr Opin Organ Transplant. 2010 Jun;15(3):310-5. doi: 10.1097/MOT.0b013e32833991f8. Review.

PMID:
20445447
16.

Prevention of hepatocellular carcinoma complicating chronic hepatitis C.

Ueno Y, Sollano JD, Farrell GC.

J Gastroenterol Hepatol. 2009 Apr;24(4):531-6. doi: 10.1111/j.1440-1746.2009.05814.x. Review.

PMID:
19368633
17.

Genomics and HCV infection: progression of fibrosis and treatment response.

Estrabaud E, Vidaud M, Marcellin P, Asselah T.

J Hepatol. 2012 Nov;57(5):1110-25. doi: 10.1016/j.jhep.2012.05.016. Epub 2012 May 30. Review.

18.

IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.

Ahlenstiel G, Booth DR, George J.

J Gastroenterol. 2010 Sep;45(9):903-10. doi: 10.1007/s00535-010-0287-4. Epub 2010 Jul 16. Review.

PMID:
20635099
19.

Management of patients co-infected with HBV and HCV.

Coffin CS, Terrault NA.

Expert Rev Anti Infect Ther. 2009 Jun;7(5):549-58. doi: 10.1586/eri.09.38. Review.

PMID:
19485795
20.

Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis.

Cobleigh MA, Robek MD.

Am J Pathol. 2013 Jan;182(1):21-8. doi: 10.1016/j.ajpath.2012.08.043. Epub 2012 Nov 14. Review.

Supplemental Content

Support Center